(Reuters) Amazon.com Inc has barred more than 1 million products
from sale in recent weeks that had inaccurately claimed to cure or
defend against the coronavirus, the company told Reuters on Thursday.
Amazon also removed tens of thousands of deals from merchants that it
said attempted to price-gouge customers. The world’s largest online
retailer has faced scrutiny over the health-related offers on its
platform, and earlier this week Italy launched a probe into surging
prices around the internet for sanitizing gels and hygiene masks while
it battled the biggest outbreak in Europe.
The coronavirus has caused at least 2,797 deaths globally. New
reported infections around the world now exceed those from mainland
China, where the flu-like disease arose two months ago out of an illegal
wildlife market. Governments from Australia to Iran have closed
schools, scrapped events and stockpiled medical supplies to contain the
virus’s spread.
One offer comparison site showed recent examples of higher-than-usual
prices for masks on Amazon made by U.S. industrial conglomerate 3M Co.
A merchant Thursday offered a 10-pack of N95 masks for $128, a
Reuters reporter saw when clicking through the buying options on Amazon.
That was up from a recent seller average price of $41.24, according to
the tracking website camelcamelcamel.com. The item was no longer
available in a check later in the day.
A two-pack respirator was offered new at $24.99 earlier this week by a
third-party seller, up from a recent average of $6.65 when sold by
Amazon, the price-following site showed.
“There is no place for price gouging on Amazon,” a spokeswoman said
in a statement, citing the company’s policy that product information
must be accurate and that Amazon can take down offers that hurt customer
trust, including when pricing “is significantly higher than recent
prices offered on or off Amazon.”
It declined to specify the exact threshold at which an item is considered unfairly priced.
The company said it has monitored for price spikes and false claims through a mix of automated and manual review of listings.
Source: Reuters; Reporting By Jeffrey Dastin in San Francisco; Editing by Peter Henderson and Cynthia Osterman

No comments:
Post a Comment